RS212100 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Pregnen-diol disulfate levels | T | OR: 0.63 | 3E-478 | PubMed |
| 4-androsten-3beta,17beta-diol disulfate (1) levels | T | OR: 0.51 | 2E-320 | PubMed |
| 4-androsten-3alpha,17alpha-diol monosulfate (3) levels | T | OR: 0.45 | 5E-240 | PubMed |
| Serum 25-Hydroxyvitamin D levels (conditioned on BMI) | T | β: 0.066 | 1E-135 | PubMed |
| 25-hydroxyvitamin D levels (skin colour stratified) | T | β: 0.065 | 7E-126 | PubMed |
| Metabolite levels (pregnen-diol disulfate; pregnenediol disulfate (C21H34O8S2); pregnen-diol disulfate C21H34O8S2) | C | OR: 0.55 | 2E-106 | PubMed |
| Metabolite levels (4-androsten-3beta,17beta-diol disulfate (1); androstenediol (3beta,17beta) disulfate (1)) | C | OR: 0.45 | 6E-75 | PubMed |
| X-21471 levels | C | OR: 0.33 | 1E-55 | PubMed |
| Metabolite levels (4-androsten-3alpha,17alpha-diol monosulfate (3); androstenediol (3alpha, 17alpha) monosulfate (3)) | C | OR: 0.4 | 5E-54 | PubMed |
| 21-hydroxypregnenolone disulfate levels | T | OR: 0.21 | 6E-53 | PubMed |
| X-21441 levels | C | OR: 0.27 | 2E-37 | PubMed |
| Plasma androstenediol (3alpha, 17alpha) monosulfate (2) levels in chronic kidney disease | C | OR: 0.28 | 3E-37 | PubMed |
| Glycodeoxycholate 3-sulfate levels | C | OR: 0.25 | 3E-32 | PubMed |
| Gallstone disease | — | OR: 1.16 | 2E-31 | PubMed |
| 4-androsten-3beta,17beta-diol monosulfate (1) levels | T | OR: 0.13 | 9E-23 | PubMed |
| Urine X-21851 levels in chronic kidney disease | C | OR: 0.24 | 1E-17 | PubMed |
| Plasma androsterone glucuronide levels in chronic kidney disease | C | OR: 0.24 | 2E-17 | PubMed |
| Urine androsterone glucuronide levels in chronic kidney disease | C | OR: 0.23 | 1E-15 | PubMed |
| 21-hydroxypregnenolone disulfate levels | C | OR: 0.16 | 1E-15 | PubMed |
| X-24546 levels | C | OR: 0.16 | 2E-12 | PubMed |